TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

ST Pharm at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

ST Pharm takes part in 1 session at TIDES Europe 2026 in Amsterdam, and exhibits at Booth 503. Its session covers process development for antibody–oligonucleotide conjugates built on engineered cysteines. The specific topics are pooling purification fractions by drug-to-antibody ratio, validating orthogonal analytical methods and finding where the oligonucleotide attaches.

OrganizationTIDES Europe 2026 Attendance
ST Pharm
Seoul, South Korea
CDMO & CROGold sponsor
South Korean contract developer and manufacturer of oligonucleotide APIs, also producing phosphoramidites and offering mRNA services.
Booth
Exhibiting at Booth 503
Tue, Nov 33:00pm–6:30pmWed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm
Talk
Tue Nov 3
12:15–12:45
Engineered Cysteine AOC Process Development: DAR-Guided Fraction Pooling, DAR Blend-Validated Orthogonal Methods, and Conjugation Site Determination
Ways to purify and measure antibody–oligonucleotide conjugates made on engineered cysteines, pooling fractions by how many oligonucleotides each antibody carries.
OligonucleotidesCMC & Manufacturing

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at ST Pharm

Tell us what you sell and we’ll find the people at ST Pharm most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction